Pfizer scoops up Global Blood Therapeutics and its sickle cell therapies for $5.4B - Endpoints News
8/8/2022 12:00:00 AM2 years 8 months ago
by Amber Tong
by Amber Tong
Pfizer is dropping $5.4 billion to acquire Global Blood Therapeutics. Just ahead of the weekend, word got out that Pfizer was close to clinching a $5 billion buyout — albeit with other potential buyers still at the table. The pharma giant, flush with cash fro…
Pfizer is dropping $5.4 billion to acquire Global Blood Therapeutics. Just ahead of the weekend, word got out that Pfizer was close to clinching a $5 billion buyout — albeit with other potential buy… [+529 chars]
full article...